Prevalence of hypogonadism in males aged at least 45 years: the HIM study.
about
Adverse effects of testosterone replacement therapy: an update on the evidence and controversyAn update on the role of testosterone replacement therapy in the management of hypogonadismTestosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic riskTestosterone and benign prostatic hyperplasiaTestosterone and the cardiovascular system: a comprehensive review of the clinical literaturePreserving fertility in the hypogonadal patient: an updateStem cell therapy for the treatment of Leydig cell dysfunction in primary hypogonadismPatient satisfaction with testosterone replacement therapies: the reasons behind the choicesPremature decline of serum total testosterone in HIV-infected men in the HAART-eraEnclomiphene citrate for the treatment of secondary male hypogonadism.Predicting low testosterone in aging men: a systematic review.Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study.Prevalence of low testosterone in aging men with benign prostatic hyperplasia: data from the Proscar Long-term Efficacy and Safety Study (PLESS).Does early morning versus late morning draw time influence apparent testosterone concentration in men aged > or =45 years? Data from the Hypogonadism In Males study.Testosterone deficiency in adults and corresponding treatment patterns across the globe.A critical analysis of testosterone supplementation therapy and cardiovascular risk in elderly men.Association between hypogonadism, symptom burden, and survival in male patients with advanced cancerTestosterone concentrations in diabetic and nondiabetic obese men.Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency.Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men.Late-onset hypogonadism.Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS).Testosterone deficiency and replacement: Myths and realities.The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.Testosterone modifies the effect of APOE genotype on hippocampal volume in middle-aged men.Testosterone and weight loss: the evidence.A practical guide to male hypogonadism in the primary care setting.Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications.Oxidative stress, testosterone, and cognition among Caucasian and Mexican-American men with and without Alzheimer's diseaseMen's Health Index: a pragmatic approach to stratifying and optimizing men's healthTestofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study.Prediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and metabolic syndrome.Pituitary insufficiency after operation of supratentorial intra- and extraaxial tumors outside of the sellar-parasellar region?Genetic and phenotypic variation in UGT2B17, a testosterone-metabolizing enzyme, is associated with BMI in males.Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men.Testosterone replacement and cardiovascular safety: no straight and narrow!Treatment of hypogonadotropic male hypogonadism: Case-based scenarios.Vitamin D is associated with testosterone and hypogonadism in Chinese men: Results from a cross-sectional SPECT-China study.Hypogonadism in male cancer patients.
P2860
Q24564836-76579790-795E-4A0F-9ED5-4CC00FE57FBAQ26749076-D4811FB1-9A6D-4399-B2B2-B7EC225EA08EQ26775766-2AECB933-8507-4B96-81A5-9DB21861DBD9Q26863719-88FD466A-BE80-4655-BC31-3F219CE8A9B1Q27000507-FFC53B1B-2114-49B3-804F-A8A84E69FE69Q27027785-8371A3CF-5566-4FC6-A458-6D38F81E3017Q28073776-E9262957-CD3D-4A76-B66D-C77F8321239FQ28304192-BA2BF177-17B5-47CC-ABE8-0E6345126C12Q28478337-B9521700-EEB6-4C4E-A495-B3D7D29B8BACQ30249404-7587DBB1-7118-4ED4-8140-740DE23B5767Q30249472-CD294887-2565-4699-8E1C-50060FC5E7FAQ30587292-E887357B-0E03-4CE4-B49C-2EA938385F87Q30597556-242E2738-8A36-4D51-AD6A-773F2123B815Q31119138-545AA0D4-BB4B-4427-BBAB-6338B9A78D2DQ33650762-07E80C49-2998-4CB1-B9E8-AD96FFE29479Q33690473-D9A8BC4C-C2B3-4D43-B641-91170F1DEFD4Q33714337-81B6F8D4-496C-45E0-BB2A-6AD6E34B914CQ33873019-D77DBBE4-62D4-414D-8409-B4971594871CQ33890197-66E22200-C566-4162-AA02-CD2A36AEFE2DQ33897720-D0824345-D469-48B6-9943-CD70B30A1069Q33900443-B8B79FA9-9338-47CE-92D7-9E4E5B8CEE67Q33903549-8ED2A85D-665B-4294-8225-A4DCB5D3303BQ34063853-B40918DA-C853-4DC3-914B-051F2C721784Q34093530-A5823390-0C91-44FE-A83E-DD9F21654CB0Q34097510-8CE24766-A047-4B00-B33D-43A872C4AFF3Q34125571-6B88A4D3-2CDB-40E9-B926-F3F0B9087DECQ34134273-E60E00A7-98D1-477A-8031-3A861EAEAD6FQ34167760-421F132A-D3D7-421D-8FB3-DC9D8DCF89F3Q34398768-F5E44D2A-29A6-4D48-955C-3135C969CEA2Q34449460-14BDA1D4-38D7-47AC-849B-F2A7E9061FBFQ34506843-5755E2C3-B92B-4B90-937D-B67E74BB9439Q34510099-A22815D8-9BBC-4CC0-9FB4-5A9C724ADC86Q34999016-8358E346-5779-4389-B4EA-AE41F9F89A0AQ35209624-E4261A5B-BAAB-4074-AF70-05FE86799150Q35243264-D832BE43-C4DB-496E-B452-B7F58BF4EF5FQ35289581-54777153-A9A4-45BD-88F9-715E37AE66F2Q35546614-C2ACC986-DC72-42A3-B24F-CC9E3F869BFDQ35567872-3C720995-522D-47BA-992A-F096BC5BF601Q35857014-A6860E8C-FBF3-452C-AE7A-E2B522AECF19Q36179123-DF096B1A-6560-44F1-9F1D-ACEB670B78C7
P2860
Prevalence of hypogonadism in males aged at least 45 years: the HIM study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Prevalence of hypogonadism in males aged at least 45 years: the HIM study.
@ast
Prevalence of hypogonadism in males aged at least 45 years: the HIM study.
@en
type
label
Prevalence of hypogonadism in males aged at least 45 years: the HIM study.
@ast
Prevalence of hypogonadism in males aged at least 45 years: the HIM study.
@en
prefLabel
Prevalence of hypogonadism in males aged at least 45 years: the HIM study.
@ast
Prevalence of hypogonadism in males aged at least 45 years: the HIM study.
@en
P2093
P2860
P1476
Prevalence of hypogonadism in males aged at least 45 years: the HIM study.
@en
P2093
P2860
P304
P356
10.1111/J.1742-1241.2006.00992.X
P577
2006-07-01T00:00:00Z